Integer Holdings Co. (NYSE:ITGR) Shares Sold by OneDigital Investment Advisors LLC

OneDigital Investment Advisors LLC lessened its stake in Integer Holdings Co. (NYSE:ITGR) by 14.0% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,092 shares of the medical equipment provider’s stock after selling 340 shares during the period. OneDigital Investment Advisors LLC’s holdings in Integer were worth $272,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds also recently made changes to their positions in the company. Blue Trust Inc. grew its position in Integer by 460.4% during the 2nd quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock worth $658,000 after purchasing an additional 4,636 shares during the last quarter. Earnest Partners LLC grew its holdings in shares of Integer by 3.2% during the second quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock worth $139,911,000 after buying an additional 37,340 shares during the last quarter. Great Lakes Advisors LLC increased its position in Integer by 56.7% in the 2nd quarter. Great Lakes Advisors LLC now owns 45,218 shares of the medical equipment provider’s stock valued at $5,236,000 after acquiring an additional 16,355 shares during the period. SG Americas Securities LLC purchased a new stake in Integer during the 3rd quarter valued at approximately $651,000. Finally, Vanguard Group Inc. lifted its position in Integer by 0.6% during the 1st quarter. Vanguard Group Inc. now owns 3,826,088 shares of the medical equipment provider’s stock worth $446,428,000 after acquiring an additional 23,382 shares during the period. Hedge funds and other institutional investors own 99.29% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research firms have recently commented on ITGR. Benchmark upped their price target on Integer from $130.00 to $140.00 and gave the stock a “buy” rating in a research note on Monday, October 21st. KeyCorp raised their target price on shares of Integer from $139.00 to $144.00 and gave the stock an “overweight” rating in a research note on Tuesday, October 15th. Piper Sandler reiterated an “overweight” rating and set a $140.00 price target (up from $125.00) on shares of Integer in a research note on Friday, October 25th. Truist Financial reduced their price objective on shares of Integer from $150.00 to $147.00 and set a “buy” rating for the company in a research report on Friday, October 25th. Finally, Citigroup boosted their target price on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. One research analyst has rated the stock with a hold rating and seven have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $139.75.

Integer Stock Performance

NYSE ITGR opened at $138.10 on Friday. The business has a 50 day moving average price of $129.99 and a 200 day moving average price of $123.25. The company has a market capitalization of $4.63 billion, a P/E ratio of 41.99, a PEG ratio of 1.91 and a beta of 1.09. Integer Holdings Co. has a 1-year low of $84.75 and a 1-year high of $140.91. The company has a debt-to-equity ratio of 0.67, a current ratio of 3.28 and a quick ratio of 2.09.

Integer (NYSE:ITGR) last announced its quarterly earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.07. Integer had a return on equity of 11.63% and a net margin of 6.70%. The business had revenue of $431.42 million during the quarter, compared to analysts’ expectations of $440.59 million. During the same quarter last year, the business posted $1.27 earnings per share. The business’s revenue for the quarter was up 8.7% on a year-over-year basis. Sell-side analysts expect that Integer Holdings Co. will post 5.34 EPS for the current fiscal year.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.